Report Detail
Global Acute Migraine Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM3539085 |
- 26 September, 2024 |
- Global |
- 101 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.
According to our (Global Info Research) latest study, the global Acute Migraine Drugs market size was valued at US$ 2337 million in 2023 and is forecast to a readjusted size of USD 3764 million by 2030 with a CAGR of 7.1% during review period.
The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.
This report is a detailed and comprehensive analysis for global Acute Migraine Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Acute Migraine Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Acute Migraine Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Acute Migraine Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Acute Migraine Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Acute Migraine Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Acute Migraine Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck, J & J, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Acute Migraine Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Triptans
NSAIDs
Others
Market segment by Application
Hospital Pharmacies
Drug Stores
Major players covered
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acute Migraine Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Acute Migraine Drugs, with price, sales quantity, revenue, and global market share of Acute Migraine Drugs from 2019 to 2024.
Chapter 3, the Acute Migraine Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acute Migraine Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Acute Migraine Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Acute Migraine Drugs.
Chapter 14 and 15, to describe Acute Migraine Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Acute Migraine Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Triptans
- 1.3.3 NSAIDs
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Acute Migraine Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital Pharmacies
- 1.4.3 Drug Stores
- 1.5 Global Acute Migraine Drugs Market Size & Forecast
- 1.5.1 Global Acute Migraine Drugs Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Acute Migraine Drugs Sales Quantity (2019-2030)
- 1.5.3 Global Acute Migraine Drugs Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Acute Migraine Drugs Product and Services
- 2.1.4 GSK Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 GSK Recent Developments/Updates
- 2.2 Teva
- 2.2.1 Teva Details
- 2.2.2 Teva Major Business
- 2.2.3 Teva Acute Migraine Drugs Product and Services
- 2.2.4 Teva Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Teva Recent Developments/Updates
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer Acute Migraine Drugs Product and Services
- 2.3.4 Pfizer Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Pfizer Recent Developments/Updates
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Acute Migraine Drugs Product and Services
- 2.4.4 Novartis Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novartis Recent Developments/Updates
- 2.5 Sun Pharma
- 2.5.1 Sun Pharma Details
- 2.5.2 Sun Pharma Major Business
- 2.5.3 Sun Pharma Acute Migraine Drugs Product and Services
- 2.5.4 Sun Pharma Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Sun Pharma Recent Developments/Updates
- 2.6 Grunenthal
- 2.6.1 Grunenthal Details
- 2.6.2 Grunenthal Major Business
- 2.6.3 Grunenthal Acute Migraine Drugs Product and Services
- 2.6.4 Grunenthal Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Grunenthal Recent Developments/Updates
- 2.7 Endo Pharmaceuticals
- 2.7.1 Endo Pharmaceuticals Details
- 2.7.2 Endo Pharmaceuticals Major Business
- 2.7.3 Endo Pharmaceuticals Acute Migraine Drugs Product and Services
- 2.7.4 Endo Pharmaceuticals Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Endo Pharmaceuticals Recent Developments/Updates
- 2.8 Merck
- 2.8.1 Merck Details
- 2.8.2 Merck Major Business
- 2.8.3 Merck Acute Migraine Drugs Product and Services
- 2.8.4 Merck Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Merck Recent Developments/Updates
- 2.9 J & J
- 2.9.1 J & J Details
- 2.9.2 J & J Major Business
- 2.9.3 J & J Acute Migraine Drugs Product and Services
- 2.9.4 J & J Acute Migraine Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 J & J Recent Developments/Updates
3 Competitive Environment: Acute Migraine Drugs by Manufacturer
- 3.1 Global Acute Migraine Drugs Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Acute Migraine Drugs Revenue by Manufacturer (2019-2024)
- 3.3 Global Acute Migraine Drugs Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Acute Migraine Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Acute Migraine Drugs Manufacturer Market Share in 2023
- 3.4.3 Top 6 Acute Migraine Drugs Manufacturer Market Share in 2023
- 3.5 Acute Migraine Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Acute Migraine Drugs Market: Region Footprint
- 3.5.2 Acute Migraine Drugs Market: Company Product Type Footprint
- 3.5.3 Acute Migraine Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Acute Migraine Drugs Market Size by Region
- 4.1.1 Global Acute Migraine Drugs Sales Quantity by Region (2019-2030)
- 4.1.2 Global Acute Migraine Drugs Consumption Value by Region (2019-2030)
- 4.1.3 Global Acute Migraine Drugs Average Price by Region (2019-2030)
- 4.2 North America Acute Migraine Drugs Consumption Value (2019-2030)
- 4.3 Europe Acute Migraine Drugs Consumption Value (2019-2030)
- 4.4 Asia-Pacific Acute Migraine Drugs Consumption Value (2019-2030)
- 4.5 South America Acute Migraine Drugs Consumption Value (2019-2030)
- 4.6 Middle East & Africa Acute Migraine Drugs Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 5.2 Global Acute Migraine Drugs Consumption Value by Type (2019-2030)
- 5.3 Global Acute Migraine Drugs Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 6.2 Global Acute Migraine Drugs Consumption Value by Application (2019-2030)
- 6.3 Global Acute Migraine Drugs Average Price by Application (2019-2030)
7 North America
- 7.1 North America Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 7.2 North America Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 7.3 North America Acute Migraine Drugs Market Size by Country
- 7.3.1 North America Acute Migraine Drugs Sales Quantity by Country (2019-2030)
- 7.3.2 North America Acute Migraine Drugs Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 8.2 Europe Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 8.3 Europe Acute Migraine Drugs Market Size by Country
- 8.3.1 Europe Acute Migraine Drugs Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Acute Migraine Drugs Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Acute Migraine Drugs Market Size by Region
- 9.3.1 Asia-Pacific Acute Migraine Drugs Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Acute Migraine Drugs Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 10.2 South America Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 10.3 South America Acute Migraine Drugs Market Size by Country
- 10.3.1 South America Acute Migraine Drugs Sales Quantity by Country (2019-2030)
- 10.3.2 South America Acute Migraine Drugs Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Acute Migraine Drugs Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Acute Migraine Drugs Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Acute Migraine Drugs Market Size by Country
- 11.3.1 Middle East & Africa Acute Migraine Drugs Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Acute Migraine Drugs Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Acute Migraine Drugs Market Drivers
- 12.2 Acute Migraine Drugs Market Restraints
- 12.3 Acute Migraine Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Acute Migraine Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Acute Migraine Drugs
- 13.3 Acute Migraine Drugs Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Acute Migraine Drugs Typical Distributors
- 14.3 Acute Migraine Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Acute Migraine Drugs . Industry analysis & Market Report on Acute Migraine Drugs is a syndicated market report, published as Global Acute Migraine Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Acute Migraine Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
